Hospital
Ihc Health Services, INC.
Ihc Health Services, INC. was paid $2.34M by Medicaid between Jan 2018 and Jul 2024, across 72 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 43% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES, INC.
MT PLEASANT, UT 84647
MT PLEASANT, UT 84647
33aNPI1407964398assigned 08/29/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$2.34M
24GClaims52,114
24DCodes billed72
24AFirst – last monthJan 2018 – Jul 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Utah
Rank by total paid#3 of 7
Median peer was paid$524K
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,841 | $226K | |
| 2019 | 9,959 | $362K | |
| 2020 | 10,415 | $552K | |
| 2021 | 12,447 | $603K | |
| 2022 | 9,281 | $501K | |
| 2023 | 1,003 | $57K | |
| 2024incomplete | 168 | $38K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 43% | 1,405 | 757 | $995K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 15% | 5,005 | 4,168 | $350K |
| 80050 | General health panel | 7.7% | 929 | 867 | $179K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.8% | 3,166 | 2,817 | $136K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,110 | 1,626 | $65K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.7% | 391 | 376 | $64K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.7% | 426 | 383 | $63K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.5% | 2,339 | 1,995 | $58K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2.5% | 2,040 | 1,318 | $57K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 809 | 744 | $48K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.2% | 1,742 | 1,420 | $27K |
| 80053 | Comprehensive metabolic panel | 1.1% | 4,984 | 4,227 | $26K |
60 more codes
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,825 | $22K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,186 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 835 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,007 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,132 | $20K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 534 | $17K |
| 87631 | <1% | 124 | $15K | |
| 81001 | <1% | 2,345 | $15K | |
| 85027 | <1% | 216 | $14K | |
| 80306 | <1% | 154 | $12K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,173 | $11K |
| 87081 | <1% | 175 | $10K | |
| 80061 | Lipid panel | <1% | 814 | $10K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 532 | $9K |
| J2704 | Injection, propofol, 10 mg | <1% | 326 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 830 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 122 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 568 | $4K |
| 87070 | <1% | 74 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 39 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 399 | $2K |
| 87186 | <1% | 97 | $2K | |
| 84439 | <1% | 155 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,443 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 127 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 321 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 163 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 120 | $1K |
| 84484 | <1% | 1,273 | $1K | |
| 86140 | <1% | 1,829 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 148 | $1K |
| 85610 | <1% | 248 | $1K | |
| 83735 | <1% | 573 | $969.05 | |
| 82607 | <1% | 123 | $879.62 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 16 | $847.98 |
| 83690 | <1% | 1,124 | $841.66 | |
| 83605 | <1% | 1,525 | $528.25 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 17 | $509.39 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 373 | $506.27 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 39 | $401.55 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 67 | $284.20 |
| 83655 | <1% | 13 | $193.21 | |
| 85379 | <1% | 163 | $140.03 | |
| 87040 | <1% | 32 | $39.78 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 39 | $33.44 |
| 84703 | <1% | 231 | $27.61 | |
| 82728 | <1% | 29 | $23.99 | |
| 85651 | <1% | 119 | $20.36 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 533 | $16.28 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 13 | $5.50 |
| 84100 | <1% | 168 | $1.21 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 14 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 30 | $0.00 |
| 83880 | 0% | 14 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 87088 | 0% | 13 | $0.00 | |
| 83540 | 0% | 26 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 63 | $0.00 |
| 84466 | 0% | 24 | $0.00 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 0% | 39 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Cedar City, UT | $20.40M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services INC | Sandy, UT | $11.66M |
| Ihc Health Services, INC. | Layton, UT | $11.61M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services INC | Heber City, UT | $4.31M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services, INC. | Richfield, UT | $3.87M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.